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Shared functional neural 
substrates in parkinson’s disease 
and drug‑induced parkinsonism: 
association with dopaminergic 
depletion
Se Won oh1,2, Na‑Young Shin 1,2*, Uicheul Yoon3, Intae Sin3 & Seung‑Koo Lee 2*
While drug‑induced parkinsonism (DIP) is mainly caused by blockage of the dopaminergic pathway, 
multiple neurotransmitter systems besides the dopaminergic system are involved in parkinson’s 
disease (PD). Therefore, alterations found in both DIP and PD might be manifestations of 
dopaminergic dysfunction. To prove this hypothesis, we aimed to define the areas commonly involved 
in Dip and pD and determine whether the overlapping areas were associated with the dopaminergic 
system. 68 PD patients, 69 DIP patients and 70 age‑and sex‑matched controls underwent resting‑
state functional MRI (rsfMRI). Regional homogeneity (ReHo), amplitude of low‑frequency fluctuation 
(ALFF) and fractional ALFF were calculated and compared. Afterwards, we compared mean rsfMRI 
values extracted from the overlapping areas with uptake quantitatively measured on dopamine 
transporter (DAT) images and neuropsychological test results. Compared to the controls, both PD and 
DIP patients revealed altered rsfMRI values in the right insular cortex, right temporo‑occipital cortex, 
and cerebellum. Among them, decreased ALFF in the right insular cortex and decreased ReHo in the 
right occipital cortex were correlated with decreased DAT uptake in the caudate as well as executive, 
visuospatial, and language function. Increased ReHo in the cerebellum was also correlated with 
decrease DAT uptake in the posterior and ventral anterior putamen, but not with cognitive function. 
In conclusion, the insular cortex, occipital cortex, and cerebellum were commonly affected in both PD 
and Dip patients and might be associated with altered dopaminergic modulation.
Parkinson’s disease (PD) is the leading cause of parkinsonism which is a clinical syndrome characterized by rest-
ing tremors, rigidity, dyskinesia and postural  instability1–3. The degeneration of dopaminergic neurons in the sub-
stantia nigra and dysfunction of the dopaminergic nigro-striatal pathway is the main pathophysiology of  PD4,5. 
PD is also affected by changes in non-dopaminergic neural substrates such as serotonin, noradrenaline and ace-
tylcholine, which contribute to its motor and non-motor  symptoms6. Hitherto, many studies using resting-state 
functional magnetic resonance imaging (rsfMRI) have reported intrinsic functional changes in widespread brain 
regions in  PD7,8, and these changes might be related to both dopaminergic and non-dopaminergic alterations.
Unlike PD, drug-induced parkinsonism (DIP), the second most common cause of parkinsonism, is generally 
caused by drugs blocking the dopamine D2 receptor in the  striatum9. However, the effects of other mechanisms 
set off by a variety of offenders (e.g., presynaptic dopamine storage depletion or mitochondrial respiratory chain 
dysfunction)10,11 and various underlying diseases (i.e., psychotic disorder, depression, or epilepsy)12 can affect 
the intrinsic activation pattern of the brain together. Therefore, common features in the intrinsic brain activity 
pattern of PD and DIP patients might reflect dysfunctions in the dopaminergic system – especially in postsyn-
aptic D2 receptor-related dopaminergic modulation—more specifically relevant to parkinsonian symptoms.
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Defining dopamine-related regions relevant to parkinsonism is clinically valuable. Such knowledge can pro-
vide a basis for understanding its underlying pathophysiology, setting treatment targets, and monitoring treat-
ment response.
So far, many researchers have tried to unveil the role of dopamine in the brain using positron emission tomog-
raphy with dopamine receptor radioligands and task-based fMRI with or without combined drug challenges. 
However, few researchers have studied dopamine-related intrinsic functional alterations and most have focused 
on functional connectivity or network-level  change13–15. Research on the regional influence of dopamine, which 
might be attributable to changes in functional connectivity or network-level change is still lacking.
Among several rsfMRI analytic methods, regional homogeneity (ReHo), amplitude of low-frequency fluctua-
tion (ALFF), and fractional ALFF (fALFF) are data-driven methods and can be used to investigate the intrinsic 
activation patterns of each  voxel16. ReHo measures how synchronously a particular voxel activates compared to its 
surrounding  voxels17, and ALFF and fALFF represent the power of intrinsic brain activity in a particular  voxel18,19.
So, we compared the intrinsic brain activity of PD and DIP patients to that of the controls, respectively, using 
the aforementioned rsfMRI methods. Then, we performed a conjunction analysis by extracting the overlapping 
areas in each comparison to define regions commonly involved in both patient groups. Additionally, to validate 
the association between functional change in the overlapping regions and dopamine depletion, we performed a 
correlation analysis between rsfMRI values in these areas and radioisotope uptake in the striatum on dopamine 
transporter (DAT) imaging, which represents presynaptic dopaminergic degeneration.
Results
Demographic characteristics. The demographic characteristics of the subjects are presented in Table 1. 
Years of education was significantly low in the DIP group compared to both the PD and control groups. The 
DIP group showed more symmetric motor symptoms, while the PD group showed more asymmetric involve-
ment. In terms of the asymmetrically involved side, more severe symptoms were more frequently observed on 
the right side of PD patients, while being observed more frequently on the left side of DIP patients. The mean 
K-MMSE score was significantly different between groups and was highest for controls while being lowest for 
the DIP group. Both the PD and DIP groups showed decreased performance in executive, verbal and visual 
memory, visuospatial, and language functions. In addition, the DIP group showed decreased attention/working 
memory function compared to the control group. Compared to the PD group, the DIP group showed decreased 
performance in attention/working memory, visual memory, visuospatial, and language functions (Supplemen-
tary material Table S1).
Altered intrinsic brain activity in pD and Dip patients. ALFF. Compared to the control group, the 
PD group showed decreased ALFF in the bilateral occipital area, right insular cortex and left cerebellum, and 
increased ALFF in the left parietal area. The DIP group showed decreased ALFF in the right parieto-occipital 
area and right insular cortex and increased ALFF in the bilateral paracentral lobule, right striatum and right 
Table 1.  Demographic and clinical characteristics. Unless otherwise indicated, data are presented as 
means ± standard deviations or numbers with percentages in parentheses. PD = Parkinson’s disease; DIP = drug-
induced parkinsonism; UPDRS = Unified PD Rating Scale; K-MMSE = Korean version of the mini-mental 
state examination. P values for comparison among the 3 groups, except for comparison of the UPDRS motor 
score and laterality for motor symptoms which were only compared between the PD and DIP groups. In the 
post-hoc analysis, P1 indicates P values for comparison between the PD and DIP groups, P2 for comparison 
between the PD and control groups and P3 for comparison between the DIP and control groups.
PD (n = 68) DIP (n = 69) Control (n = 70) P value
Post-hoc analysis
P1 P2 P3
Age (year) 69.7 ± 7.8 69.9 ± 7.7 67.8 ± 6.9 0.19
Male 22 (32.4%) 15 (21.7%) 20 (28.6%) 0.628
Education (year) 9.6 ± 4.6 6.6 ± 5.0 11.0 ± 5.6 < 0.001 0.002 0.235 < 0.001
UPDRS motor score 23.3 ± 9.5 24.5 ± 12.4 0.572
Motor symptoms laterality 0.001
 Right > left 32 8
 Right < left 22 16





 Calcium channel blockers 10 (14.5%)
 Antiarrhythmics 1 (1.4%)
 Multiple 18 (26.1%)
K-MMSE 26.6 ± 2.3 23.7 ± 4.8 28.5 ± 1.5  < 0.001  < 0.001 0.001  < 0.001
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temporal area, compared to the control group (Fig. 1 and Supplementary material Table S2). Therefore, both the 
PD and DIP groups showed decreased ALFF in the right insular cortex and right occipital area compared to the 
control group (Fig. 1 and Table 2).
fALFF. The PD group showed decreased fALFF in the left inferior frontal and right temporo-occipital area and 
increased fALFF in the right frontal and bilateral temporal area, compared to the control group. The DIP group 
showed decreased fALFF in the bilateral parietal and right temporal area and increased fALFF in the right stria-
tum and bilateral corona radiata (Fig. 2 and Supplementary material Table S3). So, fALFF in the right temporal 
area was significantly decreased in both patient groups (Fig. 2 and Table 2).
ReHo. Compared to the control group, the ReHo of the PD group was decreased in the bilateral occipital cor-
tex and increased in the bilateral temporal and right frontal cortices and bilateral cerebellum. The DIP group 
showed decreased ReHo in the bilateral temporo-occipital cortex and increased ReHo in the bilateral cerebellum 
(Fig. 3 and Supplementary material Table S4). Therefore, the ReHo was decreased in the right occipital cortex 
and increased in the bilateral cerebellum in both patient groups relative to the control group (Fig. 3 and Table 2).
Association between altered intrinsic brain activity and nigrostriatal dopaminergic depletion 
in pD patients. There was no significant difference for rsfMRI values between the 59 PD patients included 
in the correlation analysis and the 9 PD patients excluded from the analysis. In the included 59 PD patients, all 
Figure 1.  Regions with ALFF change compared to the control group. Red color indicates increased value and 
blue indicates decreased value. (A) The PD group showed decreased ALFF in the bilateral occipital area, right 
insular cortex and left cerebellum, and increased ALFF in the left parietal area. (B) The DIP group showed 
decreased ALFF in the right parieto-occipital area and right insular cortex and increased ALFF in the bilateral 
paracentral lobule, right striatum and right temporal area. (C) The right occipital and insular cortex showed 
decreased ALFF in both patient groups.
Table 2.  Talairach coordinates and number of voxels for overlapping regions which show common changes of 
each rsfMRI value for the PD and DIP groups compared to the controls. R right.




DIP < control and PD < control R cuneus/middle occipital cortex 71 10.0 − 79.0 11.0
DIP < control and PD < control R insula/superior temporal gyrus 31 43.0 − 1.0 − 6.0
fALFF DIP < control and PD < control R mid temporal gyrus 19 41.0 − 69.0 4.0
ReHo
DIP < control and PD < control
R cuneus 3 10.0 − 64.0 16.0
R cuneus 2 12.0 − 58.0 14.0
DIP > control and PD > control R cerebellum 33 4.0 − 54.0 − 43.0
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Figure 2.  Regions with fALFF change compared to the control group. Red color indicates increased value and 
blue indicates decreased value. (A) The PD group showed decreased fALFF in the left inferior frontal and right 
temporo-occipital area, and increased fALFF in the right frontal and bilateral temporal area. (B) The DIP group 
showed decreased fALFF in the bilateral parietal and right temporal area and increased fALFF in the right 
striatum and bilateral corona radiata. (C) The right temporal cortex showed decreased fALFF in both patient 
groups.
Figure 3.  Regions with ReHo change compared to the control group. Red color indicates increased value and 
blue indicates decreased value. (A) The PD group showed decreased ReHo in the bilateral occipital cortex, 
and increased ReHo in the bilateral temporal and right frontal cortices and bilateral cerebellum. (B) The DIP 
group showed decreased ReHo in the bilateral temporo-occipital cortex and increased ReHo in the bilateral 
cerebellum. (C) The right occipital cortex showed decreased ReHo in both groups and the bilateral cerebellum 
showed increased activity in both groups.
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five striatal subregions showed significant decrease in DAT uptake compared to the DIP patients (Supplemen-
tary material Table S5). Decreased DAT uptake in the caudate subregion was associated with decreased ALFF in 
the right insular cortex and decreased ReHo in the right occipital cortex. Decreased DAT uptake in the posterior 
and ventral anterior putamen was associated with increased ReHo in the bilateral cerebellum (Table 3).
Association between altered intrinsic brain activity and cognitive function. There was no sig-
nificant difference for rsfMRI values between the 90 subjects included in this correlation analysis and the 47 
subjects excluded from it. In the 90 included subjects, decreased ALFF in the right insular cortex was associated 
with poor performance in the COWAT_supermarket (r = 0.257, P = 0.015). Decreased ReHo in the right occipital 
cortex was associated with poor performance in the COWAT_supermarket (r = 0.247, P = 0.019), RCFT copying 
(r = 0.277, P = 0.008), and K-BNT (r = 0.214, P = 0.042). Decreased fALFF in the right temporal area was associ-
ated with better performance in the RCFT immediate recall test (r = − 0.223, P = 0.035). Complete results of cor-
relation analysis are presented in Table 4.
Discussion
In the present study, we noted changes in intrinsic functional activity in the right insular cortex, right temporo-
occipital cortex and cerebellum, common to both groups. Decreased rsfMRI values in the right insular and right 
occipital cortices were correlated with decreased DAT uptake in the caudate as well as executive, visuospatial, 
and language functions. Increased rsfMRI values of the cerebellum were also correlated with decrease DAT 
uptake in the posterior and ventral anterior putamen, but not with cognitive function. Therefore, the insular 
cortex, occipital cortex, and cerebellum might be associated with altered dopaminergic modulation in both PD 
and DIP patients.
Accumulating evidence suggests that the insula—specifically the anterior part—plays a cognitive hub in high-
level cognitive control and directing cognitive processes by switching between large-scale brain networks relevant 
Table 3.  Correlation analysis between rsfMRI values in areas showing common change and striatal DAT 
uptake. Data are presented as the Pearson’s r with P values in parentheses. *P < .05.
fALFF in right 
temporal ROI
ReHo in right 
occipital ROI
ReHo in cerebellar 
ROI
ALFF in right 
insular ROI
ALFF in occipital 
ROI
Ventral caudate 0.248 (0.058) .300 (0.021)* − 0.199 (0.13) .302 (0.02)* 0.092 (0.489)
Dorsal caudate 0.24 (0.067) .332 (0.01)* − 0.189 (0.152) .327 (0.012)* 0.051 (0.701)
Posterior putamen − 0.006 (0.966) 0.056 (0.675) − .330 (0.011)* 0.058 (0.664) 0.034 (0.796)
Ventral anterior 
putamen 0.114 (0.389) 0.177 (0.181) − .301 (0.021)* 0.198 (0.133) 0.132 (0.318)
Dorsal anterior 
putamen 0.025 (0.853) 0.171 (0.195) − 0.223 (0.089) 0.208 (0.114) 0.158 (0.233)
Table 4.  Correlation analysis between functional activity in areas showing common change and 
neuropsychological data. Data are presented as the Pearson’s r with the P values in parentheses. SVLT Seoul 
Verbal Learning Test, COWAT Controlled Oral Word Association Test, RCFT Rey Complex Figure Test, 
K-BNT Korean version of the Boston Naming Test. *P < .05; **P < .01.
Variables ALFF in right temporal ROI ReHo in right occipital ROI ReHo in cerebellar ROI ALFF in right insular ROI ALFF in occipital ROI
Digit span (forward) − 0.195 (0.065) 0.187 (0.077) 0.093 (0.384) 0.044 (0.678) − 0.219 (0.038)
Digit span (backward) − 0.046 (0.664) 0.308 (0.003)** 0.001 (0.991) 0.13 (0.221) − 0.067 (0.53)
Digit span total − 0.137 (0.197) 0.275 (0.009)** 0.054 (0.614) 0.096 (0.366) − 0.162 (0.126)
Word Stroop test − 0.104 (0.339) 0.087 (0.428) − 0.068 (0.532) 0.001 (0.992) − 0.064 (0.56)
Color Stroop test 0.201 (0.064) 0.394 (0)** − 0.076 (0.488) 0.306 (0.004)** − 0.083 (0.45)
Phonemic generative naming 0.043 (0.701) 0.184 (0.098) 0.051 (0.648) 0.022 (0.847) − 0.01 (0.932)
COWAT (animal) − 0.083 (0.439) 0.185 (0.082) − 0.075 (0.482) 0.103 (0.333) 0.179 (0.092)
COWAT (supermarket) − 0.02 (0.852) 0.247 (0.019)* − 0.073 (0.495) 0.257 (0.015)* 0.137 (0.196)
SVLT free recall − 0.019 (0.857) 0.168 (0.113) − 0.023 (0.828) 0.083 (0.439) 0.149 (0.16)
SVLT delayed recall − 0.157 (0.14) 0.073 (0.493) − 0.134 (0.209) 0.085 (0.427) 0.038 (0.726)
SVLT recognition 0.016 (0.884) − 0.03 (0.777) − 0.175 (0.099) − 0.017 (0.875) 0.074 (0.487)
RCFT immediate recall − 0.223 (0.035)* 0.119 (0.262) − 0.053 (0.619) 0.003 (0.975) − 0.058 (0.587)
RCFT delayed recall − 0.162 (0.128) 0.13 (0.222) − 0.068 (0.526) 0.017 (0.872) − 0.091 (0.392)
RCFT recognition − 0.114 (0.283) − 0.122 (0.25) − 0.025 (0.815) − 0.078 (0.463) 0.047 (0.661)
RCFT copy − 0.164 (0.124) 0.277 (0.008)** 0.001 (0.996) 0.049 (0.648) − 0.085 (0.427)
K-BNT − 0.093 (0.382) 0.214 (0.042)* − 0.115 (0.282) 0.019 (0.856) − 0.044 (0.681)
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to executive  function20,21. This function of the insula can be disrupted by dopaminergic dysfunction via the D2 
receptor in the insula (e.g., blocking the D2 receptor with drugs in DIP)12,22 or loss of dopaminergic modulation 
in the basal ganglia which is anatomically highly interconnected with the insula (e.g., presynaptic degeneration 
of the nigrostriatal dopaminergic neuron in PD)23. As one might expect, previous research showed a relationship 
between striatal dopaminergic depletion, decreased D2 receptor availability in the right insula, and decreased 
executive function in PD  patients24. Our results also showed decreased ALFF in the right insula in both patient 
groups. Moreover, decreased ALFF in the right insula was correlated with dopaminergic depletion of the caudate 
and decreased executive function, supporting earlier results showing the insula being modulated by dopamine.
Decreased ReHo in the right occipital cortex, near the visual cortex, was also correlated with dopaminergic 
depletion in the caudate. Cortical  thinning25, decreased  metabolism26,27, and decreased  connectivity28 in the 
occipital cortex have been reported even in early PD, reflecting visual dysfunction found in this  population29. 
Autopsy studies have found dopaminergic innervation in the visual cortex of humans without neurological 
 disease30 and decreased dopamine concentration in the retina, which is connected to the occipital cortex via the 
visual pathway, in PD  patients31, which suggests that dopaminergic modulation might play a role in changes in 
the occipital cortex. However, the underlying pathophysiology for these changes are still not completely under-
stood and further research is warranted.
Although the role of the cerebellum in PD also remains unclear,  hyperactivity32,  hyperconnectivity33, 
 hypermetabolism34, and volume loss of the  cerebellum35,36, which have been associated with motor and non-
motor symptoms, have been repeatedly reported in recent studies, suggesting that the cerebellum plays a sub-
stantial role in clinical manifestations of PD. Fewer studies have been performed on the role of the cerebellum in 
DIP than PD, and a previous  study3 only reported hypertrophy of the cerebellum in DIP compared with controls. 
As the cerebellum also has dopaminergic receptors (D1–3)37,38 and is anatomically connected with the substantia 
nigra via dopaminergic  projection39, dopamine might be able to modulate cerebellar function and structure. Our 
study also revealed increased ReHo in the cerebellum including the uvula of vermis, for which a previous study 
found decreased levels of dopamine D1 and D3 messenger RNA in  PD37, and the ReHo in the cerebellum was 
negatively correlated with dopaminergic depletion in the putamen. These functional, metabolic, and structural 
changes might be a compensatory process of the cerebello-thalamo-cortical loop for the hypofunction of the 
striato-thalamo-cortical  circuit40,41. These changes could also be pathological changes induced by dopaminergic 
degeneration or abnormal stimulation from a subthalamic nucleus disinhibited by striatal D2 receptor blockage 
or presynaptic dopaminergic degeneration. Unlike previous studies, we could not find significant associations 
between cerebellar change and cognitive and motor function (not shown). The mixed pathophysiology underly-
ing cerebellar change might be a possible explanation, but further investigation is needed to elucidate the clinical 
impact of cerebellar change. We also noted decreased amplitude of intrinsic activity in the posterior temporo-
occipital cortices in both PD and DIP, but without correlation with dopaminergic depletion. The functional 
change in the posterior brain cortex has been suggested to be mainly affected by the cholinergic system, rather 
than the dopaminergic  system42. As seen in previous  articles43–45, DIP patients may be in a preclinical stage of 
PD and their parkinsonism may have been unmasked by offending drugs. Therefore, unmasked preclinical 
PD manifestation with a disturbed cholinergic system in DIP patients might be a possible explanation for the 
decreased ALFF and fALFF values observed in the posterior cortical areas in our study.
The basal ganglia plays a key role in the pathogenesis of both PD and  DIP4,5,9. But in our study, there were no 
overlapping functional changes observed in the basal ganglia of both groups. In a previous longitudinal study 
with a follow-up of approximately 2 years, the basal ganglia did not show functional changes in the early stages 
of PD, but showed decreased activity in the later  stages46. The PD patients enrolled in our study were drug-naïve 
and in the early stages of PD. We think this might have at least partly affected our results, although the size of 
this effect cannot be estimated at this time.
Another noteworthy finding is that the overlapping functional changes were quite asymmetric, involving 
mainly the right hemisphere. In terms of the laterality of motor symptoms, PD and DIP patients showed different 
patterns, so, it is difficult to explain the asymmetric results of our study simply with symptom laterality. Although 
asymmetric structural and functional brain changes have also been reported in previous imaging studies on 
 PD47–49, the underlying mechanism remains unclear. Further study is necessary to elucidate the underlying 
pathophysiology of asymmetric brain involvement.
There are several limitations in this study. First, many drugs that induce DIP are antipsychotics. We didn’t 
consider the underlying psychiatric problems that require the use of antipsychotics. So, in some cases, the 
underlying psychiatric disease could have affected the resting-state activity of the brain. Also, not all patients 
were included in the correlation analyses between intrinsic brain activity and DAT uptake and between activity 
and NP test results, so this could cause a selection bias. However, we compared values of intrinsic brain activity 
between the included and excluded subjects, and found no significant difference.
In conclusion, we demonstrated common changes of intrinsic activity in PD and DIP patients using rsfMRI 
analysis. Both groups showed altered activities in the insular cortex, medial occipital cortex and cerebellum and 
these functional changes were correlated dopaminergic depletion, suggesting these areas as regions relevant to 
parkinsonism affected via dopaminergic modulation.
Methods
Subjects. Between August 2011 and June 2016, age-and sex-matched 68 drug-naïve PD patients, 69 DIP 
patients and 70 controls who underwent MRI were recruited. PD was diagnosed according to the clinical criteria 
of the United Kingdom (UK) PD Society Brain  Bank50. DIP was diagnosed with the following criteria: (1) pres-
ence of at least two of the four cardinal signs of PD (i.e., resting tremor, rigidity, dyskinesia and postural instabil-
ity), (2) absence of a history of extrapyramidal disorders prior to treatment with an offending drug, (3) onset of 
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parkinsonian symptoms during treatment with the offending drug, and (4) symptom resolution or significant 
improvement after ceasing the offending drug. To ensure clinical diagnostic accuracy, only patients who revealed 
decreased uptake in the posterior putamen on DAT imaging were included in the PD group, while those with 
normal uptake were included in the DIP group. Patients with focal brain lesions, multiple old lacunes in the 
basal ganglia, or extensive white matter hyperintensities out of the normal range were excluded. Patients with 
Parkinsonian plus syndromes or other neurodegenerative diseases and medical comorbidities that might con-
tribute to cognitive dysfunction were also excluded. Participants who had no active neurologic or psychologic 
disorders and no cognitive complaints with a minimal score of 27 on the Korean version of the mini-mental state 
examination (K-MMSE) were included in the control group. All data were collected in accordance with relevant 
guidelines and regulations.
Standard protocol approvals, registrations, and patient consents. The Institutional Review 
Board of Severance Hospital approved this retrospective study and waived the need for informed consent as 
part of approval since we used retrospective de-identified data collected during outpatient visits. In addition, all 
methods were performed in accordance with the approved guidelines.
Assessment of clinical information. The Unified PD Rating Scale Part III (UPDRS-III) was used to 
assess parkinsonian motor symptoms in all PD patients and 46 of the DIP patients. We separately summed 
up the scores for resting tremor, active tremor, rigidity, finger tapping, hand movement, and rapid alternative 
movements of hand and leg agility for each side according to UPDRS III. Then we defined functional changes 
as asymmetric when the difference between the right and left scores was more than two points, as was done in a 
previous  study51. The self-rating Beck Depression  Inventory52 was used to assess depressive symptoms in patients 
with PD (n = 66) and DIP (n = 49). A history of vascular risk factors including hypertension, diabetes mellitus, 
hyperlipidemia, and smoking was also investigated.
To assess cognitive status, the Seoul Neuropsychological Screening Battery (SNSB)53, a detailed neuropsy-
chological (NP) test, was used in 66 of the PD patients, 33 of the DIP patients and 45 of the controls. The SNSB 
is comprised of (1) the forward and backward digit span tests and Stroop Test (word and color reading of 112 
items during a 2-min period) for attention/working memory, (2) phonemic and semantic Controlled Oral Word 
Association Test (COWAT) for frontal/executive function, (3) Seoul Verbal Learning Test (SVLT; immediate 
recall, 20-min delayed recall, and recognition) and Rey Complex Figure Test (RCFT; immediate and 20-min 
delayed recall, and recognition) for verbal/visual memory, (4) the Korean version of the Boston Naming Test 
(K-BNT) for language, and (5) RCFT copying for visuospatial function.
Image acquisition. All participants underwent fMRI scanning with a 3.0T MRI scanner (Achieva, Philips 
Medical System, Best, Netherlands) to obtain T2*-weighted single-shot echo-planar imaging sequences with the 
following parameters: 165 axial volume scans: voxel size, 2.75 × 2.75 × 3.0 mm3; slice number, 31 (interleaved); 
matrix, 80 × 80; slice thickness, 3.0 mm; gap, 1.0 mm; repetition time (TR), 2000 ms; echo time (TE), 30 ms; and 
field of view (FOV), 220 mm. Subjects were instructed to rest and keep their eyes closed without sleeping, mov-
ing, or thinking about anything specific for 5 min 30 s.
A 3D-T1-turbo field echo sequence was also obtained with the following parameters: axial acquisition with 
FOV, 220 mm; voxel size, 0.98 × 0.98 × 1.2 mm3; TR, 9.6 ms; TE, 4.6 ms; flip angle, 8°; no gap; and total acquisi-
tion time, 5 min 29.3 s.
DAT scans were performed with a GE PET-CT DSTe scanner (GE Discovery STE, GE Healthcare Technolo-
gies, Milwaukee, WI), which obtained images with a 3D-resolution of 2.3 mm thickness at half-maximum. All 
participants fasted for at least 6 h before DAT scanning. Each patient received 5 mCi (185 MBq) of 18F-FP-CIT 
intravenous injection, and images were acquired in the 3D mode at 120 KVp and 380 mAs during a 20-min ses-
sion that took place 90 min after each injection.
image analysis. rsfMRI imaging preprocessing. As was done in our recently published  study16, rsfMRI 
preprocessing and statistical analyses were performed using AFNI (https ://afni.nimh.nih.gov/), MATLAB-based 
statistical parametric mapping software (SPM8, Wellcome Department of Imaging Neuro-Science, London, 
U.K.) and Data Processing Assistant for Resting-state fMRI (DPARSF, version 4.1; https ://www.restf mri.net). We 
first despiked EPI data with AFNI’s 3d Despike algorithm to reduce the impact of outliers. The first 3 volumes 
of each image were discarded for magnetization stabilization, and the remaining 162 images were included in 
further analyses. Slice-timing correction was done by resampling all slices relative to the middle slice (i.e., 31st 
slice) in temporal order. When all functional volumes were realigned to the first volume to correct for head 
movement in SPM, six head motion parameters (three for translation and three for rotation) were calculated by 
interpolating movement over time during  acquisition54. A maximal displacement of more than 3 mm or 3 de-
grees during an entire imaging scan was exclusion criteria for this study, but no data exceeded the criteria. Next, 
the functional images were co-registered to the T1-weighted image and spatially normalized to the Montreal 
Neurological Institute (MNI) template provided with SPM8, then resampled into 3-mm cubes. Smoothing was 
then performed only for ALFF and fALFF analyses with a 4-mm full-width, half-maximum (FWHM) isotropic 
Gaussian kernel. Functional images for ReHo analysis were not smoothed, but subsequent processes were identi-
cal to those of ALFF and fALFF analyses. Band-pass filtering (0.01–0.08 Hz) was then applied to the time series 
to reduce possible high frequency noise and signal drift, and each voxel was detrended to remove linear trends. 
Linear regression was estimated with six motion parameters, the CSF signal, the white matter (WM) signal, and 
the global mean as covariates to remove the head motion effect and other possible artifacts.
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rsfMRI data analysis. Each rsfMRI value was calculated with the same methods used in our previous  study16. 
ReHo represents the degree of regional similarity in intrinsic brain activation and is assessed by calculating Ken-
dall’s coefficient of concordance (KCC) for the time series of a given voxel with those of its nearest 26 neighbors 
in a voxel-wise  manner55. The formula for calculating the KCC is as follows:
K is the number of voxels within each cluster, n is the number of ranks, and Ri is the sum of the ranks at the 
ith time  point17. The KCC value can range from 0 to 1, and values closer to 1 indicate high similarity within a 
calculated cluster.
ALFF and fALLF represent the power or amplitude of intrinsic brain activity in a given voxel. To calculate 
ALFF, we transformed the time series for each voxel into the frequency domain using a fast Fourier transform 
after band-pass filtering and then obtained the power spectrum. As the square of the amplitude of a given 
frequency component is proportional to the power of this frequency, the square root was calculated at each 
frequency of the power spectrum and the averaged square root was then calculated across 0.01–0.08 Hz. This 
averaged square root was defined as ALLF. fALFF, the normalized index of ALFF, is defined as the ratio of a power 
within a specific low-frequency range to that of the entire detectable frequency range, and is considered to better 
reflect the resting-state of the brain than  ALFF56. To reduce the global effects of variability across participants, 
each result map was respectively normalized by the global mean of the ReHo, ALFF and fALFF values.
To define differences in ReHo, ALFF, and fALFF between PD and DIP patients compared to the control group, 
respectively, we conducted pair-wise t-tests between the three groups in a voxel-wise manner using ANOVA 
contrast including age, sex, duration of education, and MMSE scores as covariates of no interest. All statistical 
analyses were corrected for multiple comparisons based on Monte Carlo simulations (3dClustSim, AFNI, https ://
afni.nimh.nih.gov). The results were set at an individual P value < 0.005 and a cluster size of 40 voxels correspond-
ing to a corrected P < 0.05/3 in order to correct for the total number of comparisons between the three groups 
by applying a Bonferroni-like adjustment to the t-test significance level. Afterwards, a conjunction analysis was 
performed by extracting intersection in the comparative analysis results (PD vs. control and DIP vs. control) 
to identify areas showing altered activation common to PD and DIP patients compared to the control group.
Quantitative analysis of DAt imaging data. The following image processing steps were applied based 
on a previous study in our  institution57 to define a ROI from the DAT imaging data automatically, as described in 
detail  elsewhere58–62. At first, the native MR images of all subjects were registered onto a template using a linear 
transformation and corrected for intensity non-uniformity  artifacts58. All non-brain parts of the image including 
the skull and meninges were removed by an automated brain extraction  algorithm59. A hierarchical multi-scale 
non-linear fitting algorithm was then applied (1) to normalize the individual MR images in stereotaxic space, 
(2) to provide a priori information, i.e. tissue probability maps for subsequent tissue classification using a neu-
ral network classifier, and (3) to obtain the 3D deformation vector field that maps the individual brain volume 
onto the  template61,62. An artificial neural network classifier was applied to identify gray matter (GM), WM and 
CSF. Partial volume errors (PVE) due to tissue-mixing at their interfaces were estimated and corrected using 
trimmed minimum covariance determinant  method60,61. A maximum probability atlas defining all of the major 
lobes and subcortical ROIs of the brain was warped to match each subject, and the intersection of this atlas with 
GM and WM classifications yielded striatal ROI masks including the caudate and putamen which were used to 
analyze the DAT imaging  data63. We then divided the caudate nucleus into ventral (z ≤ 0) and dorsal (z > 0) parts, 
the putamen into anterior (y > 0) and posterior (y ≤ 0) parts, and the anterior putamen into ventral (z ≤ − 4) and 
dorsal (z > 0) parts based on the MNI space  coordinates64,65 (Supplementary material Fig. S1). A GM mask was 
generated and included as an explicit mask to perform group comparisons exclusively within the GM voxels.
Individual DAT images were co-registered to the corresponding MRI using a rigid body transformation in 
order to apply a subcortical ROI mask. All voxels in the co-registered DAT images were divided by the mean 
uptake of the occipital GM over an established threshold (0.9) of GM PVE in each subject to form the specific 
to nonspecific binding ratio (SNBR) image. Finally, a regional mean SNBR was calculated in each striatal ROI.
correlation analysis between rsfMRi values and DAt uptake in pD patients. To define whether 
altered functional activities common to both PD and DIP patients compared to the control group were associ-
ated with dopaminergic depletion, we performed a correlation analysis between the rsfMRI values in the over-
lapping ROIs and SNBR in the striatal ROIs. We included only 59 PD patients who underwent DAT scans and 
MR scanning at an interval of 2 months or less in this analysis as DIP patients have normal DAT uptake in the 
striatum and as such, correlation results would not adequately reflect dopaminergic depletion in the brains of 
these patients.
correlation analysis between rsfMRi values and np test results. Correlation analyses were per-
formed to assess the relationship between the rsfMRI values in the overlapping ROIs and NP test results which 
showed remarkable differences in both the PD and DIP groups compared to the control group. To reduce the 
possibility of change in cognitive status on the MR scanning date compared to that on the NP test date, patients 
(61 PD and 29 DIP) with an interval of 2 months or less between the rsfMRI and NP tests were included for 
analysis. For each ROI, mean values were extracted from the ALFF, fALFF, and ReHo z-score maps with a 4-mm 
radius sphere centered at the peak. Then, correlation coefficients between the z values and the NP tests results 
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Statistical analysis. To compare the demographic characteristics of study subjects between the three 
groups, the χ2 test and Kruskal–Wallis test were used for categorical and continuous variables, respectively. For 
two-group comparisons, the independent two-sample t-test and Mann–Whitney U test were used according 
to the normality status confirmed by the Kolmogorov–Smirnov test. All data in the comparison analyses are 
expressed as means (standard deviations [SDs]). All correlation analyses were examined by Pearson’s correlation 
coefficient. Statistical analyses were performed using commercially available software (SPSS, Ver.24.0), and a 
two-tailed P value < 0.05 was considered significant.
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author upon request.
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